APVO icon

Aptevo Therapeutics
APVO

Overview Fund Trends Analyst Outlook Journalist POV

5 hedge funds and large institutions have $1.79M invested in Aptevo Therapeutics in 2020 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
5
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.77M
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$112K

Top Sellers

1
-$2.73M
2
-$654K
3
-$354K
4
UBS Group
UBS Group
Switzerland
-$115K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$94K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$670K
2
$587K
3
$223K
4
$131K
5
$81K
6
$43K
7
$38K
8
$8.47K
9
$4K
10
$3K
11
$2K
12
$1K
13
$1K
14
$1K
15
$1K
16
–
17
–
18
–
19
–
20
–
21
–
22
–
23
–
24
–
25
–
1
2